Here is how C4 Therapeutics, Inc. (CCCC) and Illumina (ILMN) have performed compared to their sector

Does C4 Therapeutics, Inc. (CCCC) have what it takes to be a top stock pick for momentum investors?

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3

Here is how C4 Therapeutics, Inc. (CCCC) and Clene Inc. (CLNN) have performed compared to their sect

At the 100 µg Recommended Phase 2 Dose (RP2D), Cemsidomide Demonstrated a 53% Overall Response Rate,

I initiate C4 Therapeutics (CCCC) with a "Buy rating," driven by robust progress of its next-gen CEL

C4 Therapeutics (CCCC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about

Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries,

WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a cli

WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a cli

Here is how C4 Therapeutics, Inc. (CCCC) and Contineum Therapeutics, Inc. (CTNM) have performed comp

US stocks mixed, Nasdaq up 200 points. Dow down 0.43%, Nasdaq up 0.79%, S&P 500 up 0.27%. Commun

Vishay Intertechnology (VSH) stock up 10%, Velo3D (VELO) up 35.5%, VNET (VNET) up 32.5%, C4 Therapeu

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.2 per share versus the Zacks Conse

WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a cli

C4 Therapeutics said on Thursday it has entered into a deal ​focused on research and development of

Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Th

C4 Therapeutics, Inc. (NASDAQ: CCCC - Get Free Report) was the target of a large increase in short i

Here is how C4 Therapeutics, Inc. (CCCC) and Align Technology (ALGN) have performed compared to thei

Novel Combination Regimen Positions Cemsidomide for Use in Earlier Lines of Therapy Novel Combinatio

C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcrip

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tig

WATERTOWN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a c

  On Tuesday, 647 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

  During Monday's trading, 1214 companies set new 52-week lows.